Articles tagged "Outcome"

2016 American Transplant Congress
Which Is the Predictable Value of Post-Transplant HCC Recurrence Between Tumor-Related Factors at the Initial Diagnosis and the Transplantation?
J. Lee,^1,2 J. Lee,¹ J. Lee,³ S. Song,¹ J. Lee,¹ S.-K. Kwon,¹ M. Ju,^1,2 M. Kim,^1,2 G. Choi,^1,2 J. Choi,^1,2 S. Kim,^1,2 D. Joo.^1,2
¹Department of Surgery, Yonsei University College of Medicine, Seoul, Korea; ²Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea; ³Department of Surgery, CHA Bundang Medical Center, CHA University, Bundang, Korea.
Background: Milan criteria is best options to decide whether patients with HCC underwent liver transplantation. However, Milan Criteria is not including values at time of…
2016 American Transplant Congress
Predictors of Outcomes After Kidney Transplantation in the Setting of Chronic Opiate Use.
R. Evans,¹ N. Neville,² A. Fugit,³ R. Gedaly,¹ T. Clifford.¹
¹University of Kentucky Healthcare, Lexington, KY; ²University of Kentucky College of Pharmacy, Lexington, KY; ³Vidant Medical Center, Greenville, NC.
Purpose: To determine the impact and correlation of pre-transplant chronic opiate use with post-transplant chronic opiate use, resource utilization, and patient survival in addition to…
2016 American Transplant Congress
Assessment of Postoperative Glycemic Control in Orthotopic Heart Transplant Recipients.
J. Glick Frasiolas, J. Matthew, D. Tsapepas.
NewYork-Presbyterian Hospital, Columbia University, New York.
Hyperglycemia may occur after solid organ transplantation because of stress, immunosuppressants, and diabetes mellitus. Glycemic control has been shown to decrease morbidity and mortality in…
2016 American Transplant Congress
Outcomes for Liver Transplantation Using Organs from Donation After Cardiac Death Donors: A Single Center Experience.
J. Vanatta, X. Zhao, V. Puri, R. Helmick, S. Nair, S. Satapathy, J. Eason.
Transplantation, University of Tennessee/Methodist University Transplant Institute, Memphis, TN.
Purpose: The use of donation after cardiac death (DCD) donors provides opportunity to help meet the demand for allografts needed for liver transplantation. However, concern…
2016 American Transplant Congress
Hand-Assisted Laparoscopic Donor Nephrectomy: Experience with Over 2400 Cases at a Single Center.
H. Li,^1,2 M. Stegall,¹ G. Chow,¹ P. Dean,¹ J. Heimbach,¹ T. Taner,¹ M. Prieto.¹
¹Division of Transplant Surgery, Mayo Clinic, Rochester, MN; ²Division of Transplant Surgery, Medical University of South Carolina, Charleston, SC.
Objective: We reviewed retrospectively the 15 year experience with Hand-Assisted Laparoscopic Donor Nephrectomy (HALDN) at our institution.Methods: 2452 consecutive kidney donors underwent a HALDN between…
2016 American Transplant Congress
Single Center Experience with Robotic Kidney Transplantation for Recipients with BMI >40 kg/m²: A Comparison with the UNOS Registry.
I. Tvetanov, S. Garcia Aroz, M. Spaggiari, J. Hoonbae, J. Oberholzer, E. Benedetti.
Surgery, University of Illinois, Chicago, IL.
Introduction:Obesity represents a barrier to kidney transplantation, but the increasing prevalence amongst renal failure patients has forced some centers to carefully consider such candidates. Morbidly…
2016 American Transplant Congress
Deceased Non-A₂ Donor ABO-Incompatible Liver Transplantation – Promising Results with Anti-A/B Antibody Reduction Both Pre- and Post-Transplant.
U. Dahlgren,¹ G. Herlenius,¹ J. Mölne,² L. Rydberg,³ O. Samuelsson,⁴ W. Bennet.¹
¹Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden; ²Department of Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden; ³Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden; ⁴Department of Nephrology, Sahlgrenska University Hospital, Gothenburg, Sweden.
IntroductionOne way to expand the donor pool for patients with acute liver failure could be to use deceased donor (DD) ABO-incompatible (ABOi) liver grafts. However,…
2016 American Transplant Congress
Living Donor Liver Transplant Has Similar Outcome to Deceased Donor Liver Transplant for MELD > 25.
M. Al Sebayel,¹ F. Abaalkhail,^1,2 M. Shoukri,¹ H. Albahili,^1,2 S. Alabbad,¹ W. AlHamoudi,^1,2,3 H. Albeshbeshy,¹ H. Elsiesy.^1,2
¹Liver Transplantation, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; ²Alfaisal University, Riyadh, Saudi Arabia; ³Department of Gastroenterology, King Saud University, Riyadh, Saudi Arabia.
Background and Aims: Model for End-Stage Liver Disease (MELD) score is universally used to prioritize patients on the liver transplant (LT) waiting list. There has…
2016 American Transplant Congress
What Are the Charges and Costs of Transplanting High MELD Patients?
K. Bortecen, B. Gelb, A. Winnick, G. Morgan, L. Teperman.
Transplant Surgery, NYU Langone Medical Center, New York, NY.
Purpose: There is a significant variation in the MELD scores and subsequent morbidity among liver recipients in the US. Larger OPOs consistently serve patients with…
2016 American Transplant Congress
Long-Term Outcomes of ATG versus IL-2 Receptor Antagonist in Low Risk Kidney Transplant Recipients: Donor Factors.
F. Al Ammary, S. Bae, A. Massie, N. Desai, N. Dagher, E. Kraus, A. Wiseman, D. Segev.
JHU, Baltimore; CU, Denver.
Controversy exists regarding the optimal choice of induction therapy in low-risk kidney transplant (KT) recipients. Current guidelines specify induction choices in KT based on recipient…